As per MarkNtel The Europe Epigenetics Diagnostic Market size was valued at around USD 5.4 billion in 2024 and is projected to reach USD 13 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 15.8% during the forecast period, i.e., 2025-30.

Europe Epigenetics Diagnostic Market Systems Market Insights:

The main reasons behind this growth are the growing demand for personalized medicines, early detection of harmful chronic diseases, reduced treatment costs, enhanced treatment efficiency, and continuous investments in research and development. This is because epigenetic diagnostics helps the healthcare providers in accurately knowing about the infecting cell and give a targeted treatment to the patient which helps in reducing the cost and precisely treating the disease. Such investments also align with regional trends of rising chronic diseases, aging populations, and increasing healthcare awareness.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/europe-epigenetics-diagnostic-market.html

Europe Epigenetics Diagnostic Market Systems Market Segmentation:

By Product & Service

  • Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
  • Antibodies- Market Size & Forecast 2020-2030, USD Million
  • Chip-Sequencing Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
  • Bisulfite Conversion Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
  • Whole-Genome Amplification Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
  • 5-HMC & 5-MC Analysis Kits & Reagents- Market Size & Forecast 2020-2030, USD Million
  • Histones- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million
  • Enzymes- Market Size & Forecast 2020-2030, USD Million
  • DNA-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million
  • Protein-Modifying Enzymes- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million
  • Instruments & Accessories- Market Size & Forecast 2020-2030, USD Million
  • Software- Market Size & Forecast 2020-2030, USD Million
  • Services- Market Size & Forecast 2020-2030, USD Million

By Method

  • DNA Methylation- Market Size & Forecast 2020-2030, USD Million
  • Histone Modifications- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

By Technique

  • NGS- Market Size & Forecast 2020-2030, USD Million
  • PCR & qPCR- Market Size & Forecast 2020-2030, USD Million
  • Mass Spectrometry- Market Size & Forecast 2020-2030, USD Million
  • Sonication- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

By Application

  • Oncology- Market Size & Forecast 2020-2030, USD Million
  • Metabolic Diseases- Market Size & Forecast 2020-2030, USD Million
  • Immunology- Market Size & Forecast 2020-2030, USD Million
  • Development Biology- Market Size & Forecast 2020-2030, USD Million
  • Cardiovascular Diseases- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

By End-User

  • Academic & Research Institutes- Market Size & Forecast 2020-2030, USD Million
  • Pharmaceutical & Biotechnology Companies- Market Size & Forecast 2020-2030, USD Million
  • Hospitals & Clinics- Market Size & Forecast 2020-2030, USD Million
  • Others- Market Size & Forecast 2020-2030, USD Million

By Country

  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • The Netherlands
  • Scandinavia
  • Rest of Europe

Europe Epigenetics Diagnostic Market Recent Development:

  • 2025: Roche Sequencing Solutions introduced sequencing by expansion (SBX), a leap forward in next-generation sequencing (NGS). This innovation is fast and plays a vital role in decoding complex diseases such as cancer, immune diseases, and neurodegenerative conditions.

Tap into future trends and opportunities shaping the Europe Epigenetics Diagnostic Market complete report: https://www.marknteladvisors.com/research-library/europe-epigenetics-diagnostic-market.html

Europe Epigenetics Diagnostic Market Drivers:

Increasing Cases of Chronic Diseases Driving Market Growth – The number of cases of diseases such as cancer, heart-related diseases, nerves-related diseases, etc., are continuously increasing in this region. As per the WHO, around 20% of the deaths in Europe are caused by cancer. Also, around 32.5% of the deaths were caused by heart-related diseases in 2021. This creates a high need for detecting such problems in their earlier stages and providing the patient with personalized treatment and value-based care. This is achieved through the epigenetics diagnostic which examines the working behavior of cells and helps the healthcare provider observe the progression of treatment. This results in the increased demand for such services in Europe.

Report Highlights Essential Insights for Strategic Decision-Making

  • Detailed market size, share, and forecast analysis
    • In-depth pricing trends and segment-wise cost evaluations
    • Key industry strategies, including innovation, partnerships, and acquisitions
    • Critical value chain analysis and stakeholder profiling
    • Regional import-export market insights and trade flow assessment
    • Thorough competitive benchmarking of top hearing aid manufacturers
    • Identification of new growth opportunities and niche market segments
    • Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Europe Epigenetics Diagnostic Market are:

  • Add Diagenode
  • Oncgnostics
  • Epigenomics AG
  • PerkinElmer
  • Roche Sequencing Solutions
  • EpiCypher
  • Cambridge Epigenetix
  • Promega
  • QIAGEN
  • Agilent
  • Bio-Rad
  • Pacific Biosciences and others.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/europe-epigenetics-diagnostic-market.html

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Key Steps:

  • Define objectives and research design
  • Collect data through surveys and interviews
  • Analyze and validate data using reliable tools
  • Forecast trends and deliver actionable insights

About us:

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

Trending blog:

Reach Us:

MarkNtel Advisors

Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.